Similarly, liver, kidney, and lung tissues collected from mice 16 weeks after AAV9‐PKP2 injection revealed no significant hepatorenal or pulmonary toxicity in HE staining, except for minor vascular congestion attributable to myocardial infarction modeling (Figure S2C). This evidence concerns the gene PKP2 and myocardial infarction.